Michael Ferguson (biochemist)

Sir Michael Anthony John Ferguson CBE, FRS, FRSE (born February 1957) is a British biochemist and Regius Professor of Life Sciences at the University of Dundee. His research team are based at the School of Life Sciences, University of Dundee.[2]

Sir Michael Ferguson
Born
Michael Anthony John Ferguson

February 1957
County Durham, England[1]
Known forresearch into neglected tropical diseases
Awards
Scientific career
InstitutionsUniversity of Dundee
Websitehttp://www.lifesci.dundee.ac.uk/people/mike-ferguson

Career

He was awarded a BSc degree in biochemistry by the University of Manchester Institute of Science and Technology in 1979 and a PhD degree in biochemistry by London University in 1982. He was a postdoctoral fellow at the Rockefeller University, New York (1982–85) and at Oxford University (1985–88). He then accepted a lectureship at the University of Dundee and was promoted to Professor of Molecular Parasitology in 1994. He became Dean of Research for the School of Life Sciences at the University of Dundee in 2007, a position he held until 2014.

His main research interests concern the biochemistry of protozoan parasites that cause tropical diseases, particularly the trypanosomatida that cause human African sleeping sickness, Chagas' disease and leishmaniasis. He was heavily involved in establishing the new Drug Discovery Unit at the University of Dundee and is also co-Director of the Dundee Proteomics Facility.

He still continues to play a role in Research Strategy and directs the Discovery Centre for Translational and Interdisciplinary Research which opened in 2014. He is also a member of the Board of Governors for The Wellcome Trust and the Board of Directors of the Medicines for Malaria Venture (MMV).

Honours and awards
  • 1991: awarded Colworth Medal by the Biochemical Society to "the most promising young biochemist under 35"
  • 1993-98: Howard Hughes International Research Scholarship
  • 1994: elected a fellow of the Royal Society of Edinburgh
  • 1996: awarded Makdougall Brisbane Prize of the Royal Society of Edinburgh for "particular distinction in the promotion of scientific research".
  • 1999: International Glycoconjugate Organisation Award. A biennial award made to "a scientist who has clearly advanced the field of glycoscience and shows promise of continuing advancements".
  • 1999: elected a member of The European Molecular Biology Organisation).
  • 2000: elected a Fellow of The Royal Society (London).[3]
  • 2006: awarded the C.A. Wright Medal of the British Society for Parasitology.
  • 2007: elected a Fellow of The Academy of Medical Sciences
  • 2008: invested Commander of the Order of the British Empire (CBE) for services to science.
  • 2012: appointed a member of the Board of Governors of The Wellcome Trust
  • 2019: invested Knight Bachelor for services to science[4].
gollark: https://waitbutwhy.com/2015/01/artificial-intelligence-revolution-1.htmlhttps://www.cold-takes.com/how-digital-people-could-change-the-world/
gollark: Unfortunately, nobody actually knows how to simulate said brain, or to scan an existing one into simulation.
gollark: According to handwavey estimates, it would take 10^14-10^15 FLOPS/s to simulate a human brain. This is within reach of fairly "affordable" supercomputers now.
gollark: Intelligence isn't actually just computing power.
gollark: My consciousness runs on a 10-exaflop computing cluster instead of a foolish human brain.

References
  1. England & Wales, Civil Registration Birth Index, 1916-2007
  2. "The Ferguson Lab - biography". University of Dundee. Retrieved 2 May 2018.
  3. "Michael Ferguson biography". Royal Society. Retrieved 2 May 2018.
  4. assets.publishing.service.gov.uk (PDF) https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/768173/NY19_Queens_List__4_.pdf. Retrieved 2018-12-28. Missing or empty |title= (help)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.